Skip to main content

Bradley Campbell

Board Member

AMICUS THERAPEUTICS, INC.

CEO

AMICUS THERAPEUTICS, INC.

COO

AMICUS THERAPEUTICS, INC.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bradley Campbell

Bradley Campbell is recorded as Board Member, CEO and COO at AMICUS THERAPEUTICS, INC.. The proxy statement of AMICUS THERAPEUTICS, INC. reports total compensation of $8,526,943 for Bradley Campbell in fiscal 2024, including a base salary of $767,308. Disclosed compensation is on record for 3 fiscal years. Bradley Campbell has spoken on 22 earnings calls across 1 company, most recently for AMICUS THERAPEUTICS, INC. on November 4, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • AMICUS THERAPEUTICS, INC.

    Board Member

    Proxy statement

    Current
  • AMICUS THERAPEUTICS, INC.

    CEO

    Proxy statement

    Current
  • AMICUS THERAPEUTICS, INC.

    COO

    Proxy statement

    Current

Company network

Recorded roles and call appearances connecting this person to public companies.

AMICUS THERAPEUTICS, INC.

Current role

Board Member, CEO, COO

22 appearances Latest appearance 2025-11-04

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 AMICUS THERAPEUTICS, INC. $767,308 $8,526,943
2023 AMICUS THERAPEUTICS, INC. $698,558 $8,202,366
2022 AMICUS THERAPEUTICS, INC. $591,040 $8,997,866

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2025 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2025 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2025 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2024 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2024 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2024 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2024 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2023 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2023 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2023 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2023 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2022 Earnings Call

    AMICUS THERAPEUTICS, INC.

Show 10 earlier activities
  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2022 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2022 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2022 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2021 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2021 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2021 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q4 FY2020 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q3 FY2020 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q2 FY2020 Earnings Call

    AMICUS THERAPEUTICS, INC.

  • Earnings call

    AMICUS THERAPEUTICS, INC. Q1 FY2020 Earnings Call

    AMICUS THERAPEUTICS, INC.